Inventor · disambiguated record
Kaijiong Xiao
Also filed as: XIAO KAIJIONG
9 granted patents·10 pending applications·123 citations·filing 2017–2025
88Inventor score
Top patents by PatentIndex Score
19 records- 0198US11414433B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 16, 2022·23 cites·50 claims
- 0298US10906920B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Feb 2, 2021·29 cites·41 claims
- 0397US10806785B2Immunomodulator compounds and methods of useINCYTE CORP·Filed 2017·Granted Oct 20, 2020·32 cites·17 claims
- 0497US10618916B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2019·Granted Apr 14, 2020·31 cites·16 claims
- 0594US11472791B2Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitorsINCYTE CORP·Filed 2020·Granted Oct 18, 2022·7 cites·31 claims
- 0687US2025084104A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0786US11873309B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Jan 16, 2024·1 cites·17 claims
- 0881US12187743B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Granted Jan 7, 2025·0 cites·44 claims
- 0979US12466828B2Bicyclic amines as CDK2 inhibitorsINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·47 claims
- 1076US2025325660A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2025·Application pending·0 cites
- 1170US2023226062A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 1264US12466822B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2021·Granted Nov 11, 2025·0 cites·28 claims
- 1364US2020397893A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2020·Application pending·0 cites
- 1461US2019062345A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 1559US2019040082A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 1657US2017362253A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 1757US2018177784A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 1855US2018179202A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 1954US2024262834A1Synthesis of btk inhibitor and intermediates thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kaijiong Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →